142 related articles for article (PubMed ID: 9824115)
1. Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis.
Leung SY; Chan AS; Wong MP; Yuen ST; Fan YW; Chung LP
Hum Pathol; 1998 Nov; 29(11):1322-4. PubMed ID: 9824115
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
3. Von Hippel-Lindau disease.
Sano T; Horiguchi H
Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
5. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
7. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis.
Gilcrease MZ; Schmidt L; Zbar B; Truong L; Rutledge M; Wheeler TM
Hum Pathol; 1995 Dec; 26(12):1341-6. PubMed ID: 8522307
[TBL] [Abstract][Full Text] [Related]
8. Paratesticular Papillary Cystadenoma of the Epididymis in the Setting of von Hippel-Lindau.
Gupta S; Erickson LA
Mayo Clin Proc; 2021 Mar; 96(3):828-829. PubMed ID: 33673939
[No Abstract] [Full Text] [Related]
9. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
Siemeister G; Weindel K; Mohrs K; Barleon B; Martiny-Baron G; Marmé D
Cancer Res; 1996 May; 56(10):2299-301. PubMed ID: 8625303
[TBL] [Abstract][Full Text] [Related]
10. Bilateral papillary cystadenoma of the epididymis as a component of von Hippel-Lindau's syndrome: report of a case presenting as infertility.
de Souza Andrade J; Bambirra EA; Bicalho OJ; de Souza AF
J Urol; 1985 Feb; 133(2):288-9. PubMed ID: 3968752
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
13. Papillary cystadenoma of the epididymis.
Odrzywolski KJ; Mukhopadhyay S
Arch Pathol Lab Med; 2010 Apr; 134(4):630-3. PubMed ID: 20367315
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
15. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
16. [Papillary cystadenoma of epididymis in von Hippel-Lindau syndrome: report of a case].
Pan MH; Fan QH; Zhu Y; Yu MN
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):125-6. PubMed ID: 22455892
[No Abstract] [Full Text] [Related]
17. Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.
Los M; Aarsman CJ; Terpstra L; Wittebol-Post D; Lips CJ; Blijham GH; Voest EE
Ann Oncol; 1997 Oct; 8(10):1015-22. PubMed ID: 9402176
[TBL] [Abstract][Full Text] [Related]
18. [Epididymal cyst in von Hippel-Lindau syndrome: clinicopathologic analysis of 3 cases].
Hou Z; Luo Y; Jiang YG; Shang JF; Chen D
Zhonghua Nan Ke Xue; 2010 Feb; 16(2):142-5. PubMed ID: 20369698
[TBL] [Abstract][Full Text] [Related]
19. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
20. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
